Michel C. Nussenzweig Brazilian immunologist
Nussenzweig, Michel
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 65910642 (Personal)
Permalink: http://viaf.org/viaf/65910642
Preferred Forms
-
100 0 _
‡a
Michel C. Nussenzweig
‡c
Brazilian immunologist
-
100 1 _ ‡a Nussenzweig, Michel
-
100 1 _
‡a
Nussenzweig, Michel
-
100 1 _
‡a
Nussenzweig, Michel
4xx's: Alternate Name Forms (8)
Works
| Title | Sources |
|---|---|
| Absence of the Macrophage Mannose Receptor in Mice Does Not Increase Susceptibility toPneumocystis cariniiInfection In Vivo |
|
| A mouse model for HIV-1 entry |
|
| Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation |
|
| Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies |
|
| L-Myc expression by dendritic cells is required for optimal T-cell priming |
|
| Myeloid cells limit production of antibody-secreting cells after immunization in the lymph node |
|
| Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site |
|
| Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection |
|
| Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas |
|
| Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells |
|
| The new face of JEM. |
|
| A New Way to Diversify Antibodies by DNA Transposition |
|
| Normal host defense during systemic candidiasis in mannose receptor-deficient mice |
|
| Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens |
|
| OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development |
|
| OcaB regulates transitional B cell selection. |
|
| The origin and development of nonlymphoid tissue CD103+ DCs. |
|
| The origin of B cell recurrent chromosomal translocations: proximity versus DNA damage |
|
| Origin of the lamina propria dendritic cell network |
|
| Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA. |
|
| Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes |
|
| Persistent expression of autoantibodies in SLE patients in remission |
|
| Plasmodium Infection Promotes Genomic Instability and AID-Dependent B Cell Lymphoma |
|
| Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates |
|
| Polyreactive antibodies in adaptive immune responses to viruses |
|
| Progress toward active or passive HIV-1 vaccination |
|
| The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry |
|
| PTIP promotes chromatin changes critical for immunoglobulin class switch recombination |
|
| RAG1/2 induces genomic insertions by mobilizing DNA into RAG1/2-independent breaks |
|
| The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues |
|
| Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico |
|
| Regulation of autoreactive antibodies |
|
| Regulation of class switch recombination and somatic mutation by AID phosphorylation |
|
| Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117 |
|
| Remembering Ralph Steinman |
|
| Requirement for Ku80 in growth and immunoglobulin V(D)J recombination |
|
| Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains |
|
| Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies |
|
| Retrospective. Ralph M. Steinman (1943-2011). |
|
| Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching |
|
| Risk of Zika microcephaly correlates with features of maternal antibodies |
|
| Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1) |
|
| A robust pipeline for rapid production of versatile nanobody repertoires |
|
| A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells |
|
| Role of 53BP1 oligomerization in regulating double-strand break repair |
|
| The role of activation-induced deaminase in antibody diversification and chromosome translocations |
|
| Role of antigen receptor affinity in T cell-independent antibody responses in vivo |
|
| Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models |
|
| Role of the translocation partner in protection against AID-dependent chromosomal translocations |
|
| Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes |
|
| Secondary V(D)J recombination in B-1 cells |
|
| Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding |
|
| Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA |
|
| Sequencing and cloning of antigen-specific antibodies from mouse memory B cells |
|
| Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env |
|
| Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta |
|
| Signals that regulate lymphocyte development and differentiation. |
|
| A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection. |
|
| Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase |
|
| Somatic hypermutation shapes the antibody repertoire of memory B cells in humans |
|
| Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization |
|
| Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice. |
|
| Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo |
|
| Structural basis for germline antibody recognition of HIV-1 immunogens |
|
| Structural insights on the role of antibodies in HIV-1 vaccine and therapy |
|
| Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors |
|
| Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity |
|
| Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies |
|
| T follicular helper cell dynamics in germinal centers |
|
| T-independent type II immune responses generate memory B cells |
|
| Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys |
|
| Towards HIV-1 remission: potential roles for broadly neutralizing antibodies |
|
| Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand |
|
| Transformation by homeobox genes can be mediated by selective transcriptional repression. |
|
| Translocation capture sequencing: a method for high throughput mapping of chromosomal rearrangements |
|
| V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1 |
|
| Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state |
|
